BioIndustry Association responds to the publication of the United Kingdom Internal Market Bill
Steve Bates OBE, Chief Executive of the BioIndustry Association said: “The BIA welcomes the commitment in the Bill to preserve the UK internal market, aimed at providing certainty for businesses to work and trade freely across the whole of the UK. However, the Bill fails to provide the detail or clarity on medicine regulation and supply in Northern Ireland we have been seeking for many, many months. By seeking to put into law clauses that explicitly undermine the agreed Withdrawal Agreement, this Bill, as presented, reduces the chance of securing a deal and increases uncertainty around Britain’s future trading relationship with the European Union.”
Notes to Editors
- The United Kingdom Internal Market Bill can be found here.
- For more information please contact Jack Fellows, Communications and Media Manager on email@example.com or 07825942934
About the BIA
Established over 25 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative life sciences in the UK. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives.